Selected Publications: 2009 to 2014 Dr. Joanne Bargman

1. Tapiawala A and Bargman JM

An unusual complication in a long-term peritoneal dialysis patient (letter) Perit Dial Int 2009. 29: 120-1

2. Nessim S, Bargman JM, Austin PC, Storey K and Jassal SV

Impact of Age on Peritonitis Risk in Peritoneal Dialysis Patients: An Era Effect Clin J Am Soc Nephrol 2009. 4(1): 135-41

3. Suneja S, Chadambaram M, Herzenberg AM, and Bargman JM

Renal Involvement in Multicentric Castleman’s Disease: The Role of Cytokine-Driven Thrombotic Microangiopathy

Am J Kidney Dis 2009; 53(3): 550-4

4. Al M, Ng L, Tyrrell P, Bargman JM et al

Adipokines as Novel Biomarkers in Pediatric Systemic Lupus Erythematosus

Rheumatology (Oxford) 2009 doi: 10.1093

5. Fang W, Yang X, Bargman JM et al

The Association between Pulse Pressure and Mortality in Patients Undergoing Peritoneal Dialysis Perit Dial Int 2009; 29: 163-170

6. Harel Z, Perl J, Herzenberg A and Bargman JM

Inflammatory Pseudotumor of the Kidney Allograft Am J Kidney Dis 54: 533-7, 2009

7. Perl J and Bargman JM

The Importance of Residual Kidney Function for Patients on Dialysis: A Critical Review Am J Kidney Dis 2009. 53(6): 1068-81

8. Perl J and Bargman JM

Predialysis Interventions for Postdialysis Outcomes (Commentary) Perit Dial Int 2009 (3), 270-273

9. Zhang AH, Tam P, Leblanc D et al

Natural History of CKD Stage 4 and 5 Patients Following Referral to Renal Management Clinic Int J Urol Nephrol 2009-07-10

Epub ahead of print

10. Perl J, Bargman JM and Chan CT

Encapsulating Peritoneal Sclerosis: Lessons for the Hemodialysis Practitioner Hemodialysis International 13: 446-452, 2009

11. Dimkovic N, Aggarwal V, Khan S, Chu M, Bargman J, Oreopoulos DG

Assisted peritoneal Dialysis – what is it and who does it involve?

Advances in Peritoneal Dialysis 2009. 25: 165-70

12. Nessim SJ, Bargman JM and Jassal SV

Predictors of Peritonitis in Patients on Peritoneal Dialysis: Results from a Large Prospective Canadian Database

Clin J Am Soc Nephrol 2009. 4(7); 1195-2000

13. Glassock RJ, Bargman JM, Palmer BF et al

Nephrology Quiz and Questionnaire 2009 Clin J Am Soc Neph 2010: 5(6): 1141-60

14. Perl J, Bargman JM and Jassal SV

Peritoneal Dialysis After Non-renal Solid Organ Transplantation: Clinical Outcomes and Practical Considerations

Perit Dial Int 2010. 30: 7-12

15. Graice R and Bargman JM

Regarding “Calcium Channel Blocker-Induced Chylous Ascites in Peritoneal Dialysis Patients” (letter) Kidney Int 77(2); 165, 2010

16. Nessim S, Bargman JM and Jassal SV

Relationship Between Double-Cuff Versus Single-Cuff Peritoneal Catheters and Risk of Peritonitis Nephrol Dial Transpl 2010. 25(7): 2310-4

17. Bargman JM

The CANUSA Study and the Importance of Residual Kidney Function in Dialysis Patients (letter) Kidney Int 77: 931, 2010

18. Mujais S, Tapiawala SN, Yip PM, Al-Rowaie F, Burdzy DM, Bargman JM, Oreopoulos DG

Glucoregulatory hormones and choice of osmotic agent in peritoneal dialysis

Perit Dial Int 2010; 30(6): 626-632

19. Battistella M, Richardson R, Bargman JM et al

Improved Parathyroid Hormone Control By Cinacalcet Is Associated With Reduction In Darbepoeitin Requirement In Patients With End-Stage Renal Disease

Clin Nephrol (in press)

20. Bargman JM

Slouching towards Bethlehem: The Beast of Biocompatibility (Editorial) Nephrology, Dialysis, Transplantation 2010. 25(7): 2050-1

21. Quinn RR, Thorpe KE and Bargman JM

The higher risk of death on peritoneal dialysis in the United States is not explained by background general population mortality: the CANUSA study revisited

Clin Nephrol 2010. 73: 286-293

22. Perl J, Bargman JM and Yip P

Modification of the Glucose Correction Factor by Peritoneal Dialysis Solution Type in the Peritoneal Equilibration Test

Perit Dial Int 2010. 30(6): 647-50

23. Rioux J-P, Bargman JM and Chan CT

Systematic Differences among patients initiated on home hemodialysis and peritoneal dialysis: the fallacy of potential competition

Nephr Dial Transpl 2010

24. Yip J, Aghdassi E, Su J, Lou W, Reich H, Bargman J et al

Serum albumin as a marker of disease activity in systemic lupus erythematosus J Rheum 2010. 37(8): 1667-72.

25. Taskapan H, Theodoros P, Tam P, Bargman J and Oreopoulos D

Glomerular filtration Rate (GFR) estimated from serum creatinine predicts total (urine and peritoneal) creatinine clearance in patients on peritoneal dialysis

Int Urol Nephrol 2010: 42: 1085-92

26. Cornelis T, Rioux J-P, Bargman J et al

Home Dialysis is a Successful Strategy in Nonrenal Solid Organ Transplant Recipients with Endstage Renal Disease

Neph Dial Transpl 2010. 25(10): 3425-9.

27. Chidambaram M, Bargman JM, Quinn RR et al

Patient and Physician Predictors of Peritoneal Dialysis Technique Failure: A Population-Based, Retrospective Cohort Study

Peritoneal Dial Int 2010 (Epub ahead of print)

28. Cornelis T, Bargman JM, Chu M et al

Discordant PD catheter and effluent culture results : The limited clinical relevance of culturing PD catheters

Perit Dial Int 2010 epub June 17.

29. Zhang AH, Bargman JM, Lok CE et al

Dialysis modality choices among chronic kidney disease patients : identifying the gaps to support patient on home-based therapies

Int Urol Nephro 2010 42(3): 759-64

30. Cornelis T and Bargman JM

Sudden Increase in “urine” output in a peritoneal dialysis patient.

Perit Dial Int 2010 30(5): 574-6

31. Nessim SJ, Perl J and Bargman JM

The renin angiotensin aldosterone system in peritoneal dialysis: is what is good for the kidney also good for the peritoneum?

Kidney Int 2010. 78(1): 23-8

32. Nessim SJ, Perl J and Bargman JM

Response to ‘Effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on peritoneal transport’ (letter)

Kidney Int (in press)

33. Heywood A and Bargman JM

Coagulase-Negative Staphylococcal Peritonitis: Outcomes of Cephalosporin-Resistant Strains Advances in Peritoneal Dialysis 2010; 26: 34-6

34. Lekas P, Goldenstein PT and Bargman JM

Myocardial Dysfunction and Pulmonary Edema Post Parathyroidectomy: The Role of Hypocalcemia Advances in Peritoneal Dialysis 2010; 26: 125-9

35. Trigka K, Dousdampanis P, Chu M, Khan S, Ahmad M, Bargman JM, Oreopoulos DG

Encapsulating peritoneal sclerosis: a single-center experience and review of the literature. Int Urol Nephrol 2010 oct 6 (Epub ahead of Print)

36. Dousdampanis P, Trigka K, Chu M, Khan S, Venturoli D, Oreopoulos DG, Bargman JM

Two icodextrin exchanges per day in peritoneal dialysis patients with ultrafiltration failure: one center’s experience and review of the literature.

Int Urol Nephrol 2010 Feb 21 (Epub ahead of print)

37. Reich H, Gladman D, Urowitz M, Bargman JM et al

Persistent proteinuria and dyslipidemia increase the risk of progressive chronic kidney disease in lupus erythematosus.

Kidney Int 2011 79: 914-20

38. Perl J, Nessim SJ, Bargman JM

The biocompatibility of neutral pH, low-GDP peritoneal dialysis solutions: benefit at bench, bedside, or both?

Kidney Int 2011 79(8): 814-24

39. Perl J, Hasan O, Bargman JM et al

Impact of dialysis Modality on Survival after Kidney Transplant Failure

Clin J Am Soc Nephrol 2011 6(3): 582-90

40. Rioux JP, Cheema H, Bargman JM et al

Effect of an In-Hospital Chronic Kidney Disease Education Program among patients with Unplanned Urgent-Start Dialysis

Clin J Am Soc Nephrol 2011 6(4): 799-804

41. Rioux JP, Cheema H, Bargman JM et al

Effect of an In-Hospital Chronic Kidney Disease Education Program among patients with Unplanned Urgent-Start Dialysis

Clin J Am Soc Nephrol 2011 6(4): 799-804

42. Mehrotra R, Chiu Y-W, Kalantar-Zadeh K, Bargman JM and Vonesh E

Similar Outcomes with Hemodialysis and peritoneal dialysis in Patients With End-Stage Renal Disease Arch of Intern Med 2011 171(2): 110-8.

43. Nikalji R and Bargman JM

Severe hypoglycemia with endogenous hyperinsulinemia in a nondiabetic hemodialysis patient following parathyroidectomy

Nephrology Dialysis Transplantation 2011; doi: 10.1093/ndt/gfr120

44. Murlidharan P, Chan CT and Bargman JM

Catastrophic Hypercalcemia as a Technical Complication in Home Hemodialysis

Nephrology Dialysis Transplantation NDT Plus doi 10.1093 2011 18

45. Blake PG, Bargman JM, Brimble KS et al

Canadian Society of Nephrology Guidelines/Recommendations : Clinical practice Guidelines and Recommendations on Peritoneal Dialysis Adequacy 2011

Perit Dial Int 2011. 31(2): 218-239

46. Perl J, Wald R, McFarlane P, Bargman JM et al

Hemodialysis Vascular Access Modifies the Association Between Dialysis Modality and Survival J Am Soc Nephrol 2011, 22(6): 1113-1121

47. McQuillan R, Bharatha A, Simons M, Bargman J

Quiz Page may 2011: Sudden Loss of Consciousness During Hemodialysis Am J Kidney Dis 2011 57(5): A 23-6

48. Bargman JM

Peritoneal dialysis: An Introduction

Seminars in Nephrology: Peritoneal Dialysis Vol 31, No 2 March 2011

49. McQuillan R and Bargman JM

Hyponatremia Caused by LGI1-Associated Limbic Encephalitis NDT Plus 2011 (in press)

50. Glassock R, Bleyer A, Bargman JM and Fervenza FC

The 2010 Nephrology Quiz and Questionnaire: Part 2 Clin J Am Soc Nephrol 2011. 6: 2534-2547

51. Siccion Z, Poutanen SM, Perl J and Bargman JM

The Utility of Prolonged Culture of Peritoneal Dialysis Effluent in the Diagnosis and Management of Peritonitis

Adv Perit Dial 2011. 43-4

52. Dimitriadis C and Bargman JM Gynecologic

Issues in Peritoneal Dialysis Adv perit Dial 2011. 101-105

53. Lee SJ, Silverman ED and Bargman JM

The Role of Antimalarial Agents in the Treatment of SLE and Lupus Nephritis

Nat Rev Nephrol 2011. Vol 7: 12. p 718-729.

54. Boros C, Bradley T, Cheung M, Bargman JM et al

Early determinants of athersclerosis in paediatric systemic lupus erythematosus Clin Exp Rheumatology 2011. 29(3): 575-81

55. Pipili C, Dimitriadis C, Sekercioglu N, Bargman JM, Oreopoulos D

Effect of Nutritional Vitamin D Preparations on Parathyroid Hormone Levels in Chronic Kidney Disease Patients

Int Urol Nephrol 2012: 44: 167-171

56. Nessim SJ, Nisenbaum R, Bargman JM et al

Microbiology of Peritonis in Peritoneal dialysis patients with Multiple Episodes Perit Dial Int 2012: 316-321

57. Bargman JM

Dimitrios G. Oreopoulos – an Appreciation Clin J am Soc Nephrol 2012. 7(7): 1188-9

58. Warnock DG, Hebbar S, Bargman J et al

Prospective Safety Study of Bardoxolone methyl in Patients with Type 2 Diabetes Mellitus, Eng-Stage Renal Disease and Peritoneal Dialysis

Contrib Nephrol 2012. 178-157-63

59. Sekercioglu N, Dimitriadis C, Pipili C, Elias R, Kim J, Oreopoulos DG, Bargman JM

Glycemic Control and Survival in Peritoneal Dialysis patients with Diabetes mellitus.

Int Urol nephrol 2012. may 12 (epub)

60. Perl J, Wald R, Bargman JM et al

Changes in patient and Technique Survival over Time Among Incident peritoneal dialysis patients in Canada

Clin J Am Soc Nephrol 2012 7(7): 1145-1154

61. Holtzman S, Abbey SE, Chan C, Bargman JM, Stewart DE

A Genetic Predisposition to Produce Low levels of IL-10 is Related to Depressive Symptoms Psychosomatics 2012. 53(2): 155-61

62. Bargman JM

Should Peritoneal Dialysis be the First Option Offered to the Elderly Who Require Renal Replacement Therapy for Continued Longevity?

Seminars in Dialysis (in press)

63. Bargman JM

Advances in Peritoneal Dialysis: A Review Seminars in Dialysis (in press)

64. Dimitriadis C, Sekercioglu N, Pipili C, Oreopoulos D and Bargman JM

Hyponatremia in Peritoneal Dialysis. Epidemiology in a Single Center and Correlation with Clinical and Biochemical Parameters

Peritoneal Dialysis International (in press)